MedPage Today

FDA Approves First Disease-Specific Treatment for Warm Autoimmune Hemolytic Anemia

(MedPage Today) -- The FDA approved nipocalimab (Imaavy) as the first treatment for warm autoimmune hemolytic anemia (wAIHA), the most common form of autoimmune hemolytic anemia. Approval of the immunoselective neonatal Fc receptor (FcRn) blocker...